Márta Korbonits Selected Research

Pituitary Neoplasms (Pituitary Adenoma)

2/2022	Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes.
1/2022	Pituitary carcinoma as a rare cause of liver metastases successfully treated with temozolomide.
1/2020	Phenotypic and genotypic features of a large kindred with a germline AIP variant.
1/2019	Pituitary Pathology and Gene Expression in Acromegalic Cats.
1/2019	Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors.
1/2019	Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.
1/2019	Clinical and Pathological Aspects of Silent Pituitary Adenomas.
1/2019	Phosphodiesterases and cAMP Pathway in Pituitary Diseases.
11/2018	Reduced protein expression of the phosphodiesterases PDE4A4 and PDE4A8 in AIP mutation positive somatotroph adenomas.
6/2018	Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Márta Korbonits Research Topics

Disease

57	Pituitary Neoplasms (Pituitary Adenoma) 02/2022 - 01/2002
37	Neoplasms (Cancer) 10/2022 - 01/2002
32	Acromegaly 07/2022 - 09/2003
26	Adenoma (Adenomas) 02/2021 - 01/2002
15	Obesity 12/2016 - 08/2002
12	Carcinogenesis 01/2019 - 01/2002
11	Insulin Resistance 01/2018 - 08/2002
8	Gigantism 01/2022 - 01/2012
8	Growth Hormone-Secreting Pituitary Adenoma 11/2021 - 09/2003
8	Cushing Syndrome 01/2020 - 06/2008
7	Prolactinoma (Prolactinomas) 02/2022 - 12/2008
7	Familial Isolated Pituitary Adenoma 02/2021 - 08/2010
6	Paraganglioma (Paragangliomas) 10/2022 - 10/2012
6	Carcinoma (Carcinomatosis) 02/2022 - 06/2002
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 12/2008
5	Carney Complex 10/2022 - 01/2014
5	Hyperplasia 11/2021 - 07/2005
5	Pituitary ACTH Hypersecretion 06/2021 - 12/2003
5	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 01/2018
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2005
5	Prader-Willi Syndrome (Syndrome, Prader-Willi) 10/2014 - 04/2004
4	ACTH-Secreting Pituitary Adenoma 08/2017 - 06/2002
4	Pheochromocytoma 01/2016 - 07/2013
4	Body Weight (Weight, Body) 01/2013 - 09/2006
4	Type 2 Diabetes Mellitus (MODY) 11/2011 - 06/2007
3	Polyostotic Fibrous Dysplasia (McCune Albright Syndrome) 10/2022 - 01/2014
3	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 05/2018 - 02/2009
3	Hepatocellular Carcinoma (Hepatoma) 01/2015 - 07/2005
3	Feeding and Eating Disorders (Eating Disorder) 10/2014 - 11/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 05/2011
3	Endocrine System Diseases (Endocrine Diseases) 03/2012 - 03/2011
3	Abdominal Obesity 12/2008 - 01/2005
3	Starvation 08/2007 - 06/2005
2	Glucose Intolerance 10/2021 - 01/2005
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2014
2	Hypopituitarism (Sheehan's Syndrome) 09/2020 - 01/2020
2	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 08/2020 - 01/2014
2	Infections 01/2020 - 08/2008
2	Pituitary Apoplexy 01/2020 - 04/2014
2	Diabetes Mellitus 01/2018 - 03/2014
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2018 - 11/2015
2	Hyperparathyroidism 09/2017 - 02/2009
2	Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary) 02/2017 - 08/2012
2	Weight Gain 12/2016 - 10/2013
2	Weight Loss (Weight Reduction) 12/2016 - 11/2009
2	Hypertension (High Blood Pressure) 10/2015 - 05/2011

Drug/Important Bio-Agent (IBA)

31	aryl hydrocarbon receptor-interacting proteinIBA 01/2020 - 06/2008
27	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2002
17	GhrelinIBA 10/2014 - 08/2002
16	Growth Hormone (Somatotropin)IBA 01/2022 - 07/2005
14	Hormones (Hormone)IBA 01/2019 - 05/2005
13	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2022 - 08/2006
12	ProlactinIBA 02/2022 - 12/2003
11	Insulin-Like Growth Factor I (IGF-1)IBA 07/2022 - 09/2003
11	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2018 - 12/2003
11	Messenger RNA (mRNA)IBA 01/2015 - 01/2002
10	Insulin (Novolin)FDA Link 01/2022 - 08/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2003
10	Glucose (Dextrose)FDA LinkGeneric 04/2019 - 08/2002
9	GlucocorticoidsIBA 06/2021 - 12/2003
6	Hydrocortisone (Cortisol)FDA LinkGeneric 09/2020 - 01/2005
6	Octreotide (Sandostatin)FDA LinkGeneric 01/2019 - 08/2006
5	Temozolomide (Temodar)FDA LinkGeneric 02/2022 - 04/2009
5	MicroRNAs (MicroRNA)IBA 07/2017 - 08/2010
5	Phosphotransferases (Kinase)IBA 07/2017 - 01/2004
4	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2019 - 01/2014
4	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019 - 01/2010
4	EnzymesIBA 11/2018 - 06/2008
4	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018 - 07/2005
4	AMP-Activated Protein KinasesIBA 03/2014 - 01/2008
4	Cyclin-Dependent Kinase Inhibitor p27IBA 03/2013 - 01/2002
3	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 07/2022 - 01/2017
3	Cabergoline FDA LinkGeneric 02/2022 - 09/2017
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 06/2008
3	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2016
3	SurvivinIBA 06/2018 - 01/2010
3	Ubiquitin-Specific ProteasesIBA 05/2018 - 07/2015
3	RNA (Ribonucleic Acid)IBA 02/2018 - 12/2003
3	CarbohydratesIBA 01/2018 - 11/2009
3	somatostatin receptor 2IBA 12/2017 - 02/2016
3	Pharmaceutical PreparationsIBA 01/2015 - 06/2008
3	Ghrelin ReceptorsIBA 01/2013 - 04/2009
2	HydrocarbonsIBA 10/2022 - 01/2018
2	pegvisomant FDA LinkGeneric 07/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2021
2	Insulin-Like PeptidesIBA 07/2022 - 05/2018
2	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2021 - 08/2012
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2019 - 01/2015
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019 - 12/2017
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2019 - 12/2008
2	Pituitary HormonesIBA 05/2018 - 05/2014
2	GTP-Binding Proteins (G-Protein)IBA 12/2017 - 01/2014
2	lanreotide (Somatuline)FDA Link 12/2017 - 08/2012
2	GadoliniumIBA 12/2016 - 01/2016
2	pasireotideIBA 02/2016 - 08/2006
2	Testosterone (Sustanon)FDA Link 11/2015 - 02/2015
2	Everolimus FDA Link 01/2015 - 01/2008

Therapy/Procedure

15	Therapeutics 07/2022 - 04/2004
6	Radiotherapy 02/2022 - 04/2014
2	Drug Therapy (Chemotherapy) 12/2017 - 12/2016